FDA Approves Much-Debated Alzheimer’s Drug Panned By Experts
HuffPost
Independent advisers had warned that the much-debated treatment developed by Biogen hasn’t been shown to help slow the brain-destroying disease.
WASHINGTON (AP) — Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. The Food and Drug Administration said it granted approval to the drug developed by Biogen for patients with Alzheimer’s disease. It’s the only drug that U.S. regulators have said can likely treat the underlying disease, rather than manage symptoms like anxiety and insomnia.
The New York Times reporter responded to footage of Pam Bondi, the president-elect's pick for attorney general.
“No, this is not a, ‘Them’s the rules as usual’ kind of situation," said Harry Litman.
Not everyone is buying her excuse for the mistake.
Walmart joins a list of major corporations that have been under pressure by conservative activists.
The Tesla CEO spoke about the hazily proposed "Department of Government Efficiency" on his social media platform, X.
The "No Country for Old Men" actor revisited a bizarre evening with Trump that still haunts him to this day.
Special counsel Jack Smith, however, said the federal government continues to stand “fully behind” the merits of its original prosecution against Trump.
“You having a blue checkmark doesn’t make you a reporter," Jim VandeHei said.
Special counsel Jack Smith also moved to dismiss the 2020 election interference case against him.
Winning the 2024 election sealed the legal win for Donald Trump..
Workers have raised the alarm about their growing inability to afford basic necessities, including food and housing. Several hundred were expected to walk off the job.